Latest News
Funds advised by Equistone Partners Europe (Equistone) have acquired a majority stake in eperi, a provider of cybersecurity software for cloud applications.
The security specialist from Pfungstadt, Hessen, has been sold by venture capital investors Evolution Equity Partners and btov. Elmar Eperiesi-Beck, Founder and CEO of eperi, will continue to lead the company as CEO and retains a significant stake in the business.
The new partnership will concentrate on the company’s further scaling and internationalisation, as well as a targeted buy-and-build strategy. Both parties agreed not to disclose the financial terms of the transaction.
Vision Innovation Partners, an eye care platform and a portfolio company of Centre Partners, has acquired SIEHT, a leading eye and laser centre with two locations in Fredericksburg and Stafford, Virginia.
The acquisition broadens Vision Innovation Partners’ presence in Virginia and strengthens its growing network of ophthalmology practices in the Mid-Atlantic region.
Vision Innovation Partners is backed by Centre Partners, a leading middle-market private equity firm focused on the healthcare and consumer sectors. Centre seeks to partner with founders and management teams to build exceptional businesses, providing management teams with access to its unique resources, including an extended network of
WTW has appointed Kate Hollis as Global Head of Credit, Manager Research, in its Investments business.
In this role, Hollis is responsible for a team of over fifteen people and the ratings and performance of all Credit products representing in excess of USD250 billion of assets across WTW’s global client base. She has been promoted from her role leading the Traditional Credit research team. She will remain an Investment Committee member for WTW’s alternative credit fund (Towers Watson Investment Management Alternative Credit Fund).
Hollis joins the Manager Research leadership team whose members also include Chris Redmond, Head of Manager Research;
Finnish biotech startup Onego Bio Ltd has announced the successful closure of EUR10 million seed round with participation from venture capital investors Agronomics Limited and Maki VC.
Onego Bio’s technology, developed and researched at VTT, enables production of bioalbumen with cellular agriculture means.
Bioalbumen is an animal-free egg protein, produced with a specific precision fermentation process that creates identical egg white protein without the need for animals.
The company believes that the demand for animal-free egg white protein will be growing globally, because intensive animal farming causes many environmental hazards, such as excessive use of land, greenhouse gas emissions, water
European credit specialist AlbaCore Capital Group (AlbaCore) has launched a new solution focusing on Carbon Conscious Investing (CCI), the first European private market solution to provide line-by-line greenhouse gas (GHG) reporting for a corporate credit portfolio.
The model and methodology, developed in-house by AlbaCore, reflects the portfolio’s GHG footprint for all scenarios including when public data is not available. The GHG data is integrated into AlbaCore’s internal risk system that is monitored on an ongoing basis to continue to refine the CCI footprint analysis as data quality improves and regulatory pressure encourages more companies to report.
The CCI solution will
NexGen Cloud, a Web 3.0 focused IaaS company, has made a USD14 million investment in the development of Europe’s Largest decentralised storage project.
This investment has enabled the development of two large-scale Filecoin storage operations located in Belgium and The Netherlands, featuring Tier III data centres across both sites. Over the coming 12 months, this landmark project will provide over 100 Petabytes of data storage capabilities aimed at managed service providers (MSPs), businesses and consumers seeking more affordable storage solutions, without having to compromise on security.
The company has also announced that it has entered into a swap with
TargED Biopharmaceuticals (TargED), a private biotechnology company focused on developing improved treatments for thrombotic diseases, has raised Series A financing of EUR39 million to accelerate development of its lead compound, Microlyse.
The financing was led by an international syndicate with equal contributions from Andera Partners, Fund+, Hadean Ventures, Inkef Capital and Sunstone Life Science Ventures, and joined by existing investors FIRST (Managed by BioGeneration Ventures), Curie Capital and Utrecht Health Seed Fund.
TargED will focus development on two initial indications: acquired Thrombotic Thrombocytopenia Purpura (aTTP) and Acute Ischemic Stroke (AIS).
The Solas Sustainable Energy Fund ICAV, a new EU-focused fund targeting energy efficiency investments, has reached its first close at EUR140 million.
Strategic Investments European Fund for The European Investment Bank (EIB) committed a EUR30 million cornerstone investment to SSEF, backed by the (EFSI), the main pillar of the Investment Plan for Europe. As one of the largest providers of climate finance, the EIB supports projects that promote the priorities and objectives of the European Union.
SSEF also signed an agreement with the Private Finance for Energy Efficiency (PF4EE) support scheme, a joint initiative launched by the European Commission via
Hambro Perks has completed an investment in Finnish industrial technology business Altum Technologies.
Headquartered in Helsinki and founded in 2016, Altum has developed market-leading power ultrasound technology to clean fouling from industrial equipment without stopping production. Altum’s patented ZPD technology also minimises maintenance time, energy consumption and use of hazardous chemicals in these cleaning processes.
Altum is the latest investment from Access Fund II, the second fund in Hambro Perks’ venture secondaries franchise. The Access Fund purchases minority stakes in UK and European private technology companies, providing liquidity to early shareholders, whether they be founder, former or current management,
Beaufort Capital and Pollen Street Capital have formed a strategic joint venture to improve access to finance for high quality real estate developers nationwide.
The new lending partnership is expected to fund senior and stretched senior loans to support the development of much needed homes across the UK, as well as student accommodation, care homes and other mixed-use assets.
Beaufort Capital is an award-winning specialist real estate lender with a long track record, having financed and developed more than 5,000,000 sqft of UK real estate over 50 years. Pollen Street Capital, a private equity and credit focused manager, has
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
